Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Evaluation of a New Model of Care for People with Complications of Diabetic Retinopathy

Journal article

Lois N. et al, (2021), Ophthalmology, 128, 561 - 573

International Students Undertaking UK University-Validated Distance-Learning Courses in Diabetic Retinopathy Screening (DRS)

Conference paper

Aldington S. et al, (2020), EUROPEAN JOURNAL OF OPHTHALMOLOGY, 30, 14 - 14

Outcomes in Patients with Diabetic Macula Oedema Treated with Aflibercept for up to Three Years

Conference paper

Stratton I. et al, (2020), EUROPEAN JOURNAL OF OPHTHALMOLOGY, 30, 32 - 32

Correction to: Fundamental principles of an effective diabetic retinopathy screening program.

Journal article

Lanzetta P. et al, (2020), Acta Diabetol, 57, 907 - 908

Fundamental principles of an effective diabetic retinopathy screening program.

Journal article

Lanzetta P. et al, (2020), Acta Diabetol, 57, 785 - 798

Incidence and prevalence of moderate to severe non-proliferative diabetic retinopathy within an English Screening Programme

Conference paper

Fletcher E. et al, (2020), INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 61

Real world outcomes for aflibercept in diabetic macula edema

Conference paper

Eleftheriadis H. et al, (2020), INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 61

Aflibercept in the real world - an EPR based clinical audit of patients with diabetic macular edema from 21 UK hospitals

Conference paper

Mahmood S. et al, (2019), INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 60

Aflibercept in the real world - are the visual outcomes worse in patients with diabetic macular edema who have had a cataract operation?

Conference paper

Stratton IM. et al, (2019), INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 60

Load More